The following studies have analyzed phosphoenolpyruvate carboxykinase (PEPCK) expression in the liver of obese diabetic and obese nondiabetic Individuals. For more details and accuracy, please read the recommended references carefully.
- Bhalla and coworkers analyzed the microarray data set of livers from obese diabetic and obese nondiabetic Individuals. They observed higher levels of PEPCK in the liver of obese diabetic individuals compared to obese non-diabetic individuals (Bhalla et al., 2014).
- Experimental details:
- Microarray data set generated by Pihlajamäki and coworkers (Pihlajamäki et al., 2009)
- Organism: obese diabetic individuals than in obese nondiabetic humans
- Experimental details:
REFERENCES:
- Bhalla et al., 2014. Cyclin D1 represses gluconeogenesis via inhibition of the transcriptional coactivator PGC1α. Diabetes. 63(10), 3266-78. PMID-24947365; Supplementary Table and Figures, Full-Text Links: Diabetes journals, PMC
- Pihlajamäki et al., 2009. Thyroid hormone-related regulation of gene expression in human fatty liver. J Clin Endocrinol Metab. 94(9), 3521-3529. PMID-19549744; Full-Text Links: academic, PMC
- https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE15653
Was this post helpful?
Let us know if you liked the post. That’s the only way we can improve.
